\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ steroids\\ and\\ other\\ ms\\ medications\ \(0\)\
\-\ expansile\\ \\(infiltrative\\?\\)\\ mass\\ with\\ high\\ signal\\ on\\ t2\\ and\\ flair\\ involving\\ the\\ right\\ midbrain\\,\\ pons\\ and\\ extending\\ into\\ the\\ right\\ thalamus\\ and\\ basal\\ ganglia\\.\\ \\ minimal\\ peripheral\\ enhancement\\ noted\\.\\ \\ lesion\\ is\\ associated\\ with\\ marked\\ mass\\ effect\\ and\\ edema\\.\ \(0\)\
\-\ tumefactive\\ demyelination\\ \\(multiple\\ sclerosis\\)\ \(0\)\
\-\ \\â\\€\\¢\\ astrocytoma\ \(1\)\
\-\ \\â\\€\\¢\\ oligodendroglioma\ \(1\)\
\-\ \\â\\€\\¢\\ abscess\ \(6\)\
\-\ \\â\\€\\¢\\ inflammatory\\ demyelination\ \(0\)\
\-\ this\\ 33\\ y\\.o\\.\\ man\\ presented\\ with\\ right\\ eye\\ blindness\\ 4\\ months\\ ago\\ and\\ was\\ diagnosed\\ with\\ ms\\.\\ \\ he\\ had\\ another\\ episode\\ of\\ left\\ arm\\ and\\ leg\\ weakness\\ and\\ left\\ eye\\ blindness\\ two\\ weeks\\ ago\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ blindness\\:\\ 0\\.3378761558409736\ \(0\)\
\-\ demyelination\\:\\ 0\\.31842486053266406\ \(0\)\
\-\ ms\\:\\ 0\\.2657213562633878\ \(0\)\
\-\ and\\:\\ 0\\.22618923388736972\ \(0\)\
\-\ eye\\:\\ 0\\.2189187449081425\ \(0\)\
\-\ ago\\:\\ 0\\.20022692926635646\ \(0\)\
\-\ thalamus\\:\\ 0\\.1582332576388863\ \(0\)\
\-\ tumefactive\\:\\ 0\\.15551491063352457\ \(0\)\
\-\ midbrain\\:\\ 0\\.15231197344000344\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.1436071776565933\ \(0\)\
\-\ pons\\:\\ 0\\.1406663895039093\ \(0\)\
\-\ infiltrative\\:\\ 0\\.14020949190895474\ \(0\)\
\-\ right\\:\\ 0\\.1360915791871836\ \(0\)\
\-\ ganglia\\:\\ 0\\.12859874661149537\ \(0\)\
\-\ episode\\:\\ 0\\.1252221200385926\ \(0\)\
\-\ expansile\\:\\ 0\\.12381074835808617\ \(0\)\
\-\ 33\\:\\ 0\\.12040875277331747\ \(0\)\
\-\ steroids\\:\\ 0\\.1202113327413126\ \(0\)\
\-\ basal\\:\\ 0\\.11708223777691489\ \(0\)\
\-\ flair\\:\\ 0\\.11640172693032465\ \(0\)\
\-\ medications\\:\\ 0\\.11478040731442243\ \(0\)\
\-\ another\\:\\ 0\\.11197264213101199\ \(0\)\
\-\ arm\\:\\ 0\\.10920951187721994\ \(0\)\
\-\ with\\:\\ 0\\.10716986191676373\ \(0\)\
\-\ mass\\:\\ 0\\.10452863311077959\ \(0\)\
\-\ minimal\\:\\ 0\\.10438484892137428\ \(0\)\
\-\ marked\\:\\ 0\\.10348712424479535\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.10329211180084308\ \(0\)\
\-\ leg\\:\\ 0\\.10329211180084308\ \(0\)\
\-\ weakness\\:\\ 0\\.09985963794198217\ \(0\)\
\-\ diagnosed\\:\\ 0\\.09911388673144082\ \(0\)\
\-\ peripheral\\:\\ 0\\.09784278678685251\ \(0\)\
\-\ sclerosis\\:\\ 0\\.09745899622344803\ \(0\)\
\-\ effect\\:\\ 0\\.09598244407217157\ \(0\)\
\-\ involving\\:\\ 0\\.0958396674691645\ \(0\)\
\-\ left\\:\\ 0\\.0933494463578215\ \(0\)\
\-\ available\\:\\ 0\\.0928332679735879\ \(0\)\
\-\ extending\\:\\ 0\\.09277055839935126\ \(0\)\
\-\ inflammatory\\:\\ 0\\.09252134682270245\ \(0\)\
\-\ abscess\\:\\ 0\\.0878605976660494\ \(0\)\
\-\ weeks\\:\\ 0\\.08200319206279805\ \(0\)\
\-\ edema\\:\\ 0\\.08160671363954561\ \(0\)\
\-\ two\\:\\ 0\\.08125540127923704\ \(0\)\
\-\ he\\:\\ 0\\.08102401943535233\ \(0\)\
\-\ presented\\:\\ 0\\.07978984051988741\ \(0\)\
\-\ months\\:\\ 0\\.0796444679628937\ \(0\)\
\-\ enhancement\\:\\ 0\\.07875532248308134\ \(0\)\
\-\ t2\\:\\ 0\\.07872043317004526\ \(0\)\
\-\ high\\:\\ 0\\.07776358385596815\ \(0\)\
\-\ signal\\:\\ 0\\.07756341803387097\ \(0\)\
\-\ into\\:\\ 0\\.07273495453895581\ \(0\)\
\-\ noted\\:\\ 0\\.07254555164916356\ \(0\)\
\-\ man\\:\\ 0\\.07243798914387833\ \(0\)\
\-\ associated\\:\\ 0\\.07211816575925402\ \(0\)\
\-\ other\\:\\ 0\\.07105653286805384\ \(0\)\
\-\ had\\:\\ 0\\.06817231413580904\ \(0\)\
\-\ multiple\\:\\ 0\\.06692513426784304\ \(0\)\
\-\ lesion\\:\\ 0\\.06559797686482333\ \(0\)\
\-\ the\\:\\ 0\\.05460394641577329\ \(0\)\
\-\ not\\:\\ 0\\.05401610185989637\ \(0\)\
\-\ was\\:\\ 0\\.04768561449967573\ \(0\)\
\-\ this\\:\\ 0\\.047016270894606874\ \(0\)\
\-\ on\\:\\ 0\\.04132414622994014\ \(0\)\
\-\ is\\:\\ 0\\.03747104311740954\ \(0\)\
\-\ of\\:\\ 0\\.026776466546809694\ \(0\)\
